A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial (Q92145080)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

title

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

phase II clinical trial

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Sylvia L. Asa

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Grainne M O'Kane

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Shereen Ezzat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Isabelle Bourdeau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Raya Leibowitz-Amit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Harold J Olney

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Monika Krzyzanowska

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Dean Reuther

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Soo Chin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Lisa Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Kelly Brooks

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Aaron R Hansen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

Jennifer J Knox

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

publication date

20 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

British Journal of Cancer

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

1113-1119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

27 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Pathology and genetics of phaeochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Role of VHL gene mutation in human cancer

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

A 15-year experience with chemotherapy of patients with paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Alterations in VHL as potential biomarkers in renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Outcomes of Patients with Metastatic Phaeochromocytoma and Paraganglioma: a Systematic Review and Meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies

1 reference

https://api.crossref.org/works/10.1038/S41416-019-0474-X

7 January 2021

10.1038/S41416-019-0474-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31105270 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference